Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings
Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings. // Endocrine Practice. – URL: https://www.sciencedirect.com/science/article/pii/S1530891X26012887?dgcid=rss_sd_all
Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings. Endocrine Practice. https://www.sciencedirect.com/science/article/pii/S1530891X26012887?dgcid=rss_sd_all
“Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings.” Endocrine Practice.
@article{article89151,
title = {Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals With Type 2 Diabetes From Primary Care and Endocrinology Settings},
journal = {Endocrine Practice},
url = {https://www.sciencedirect.com/science/article/pii/S1530891X26012887?dgcid=rss_sd_all}
}